Cleared Traditional

K191492 - Maxxi Position Sensor

K191492 is the FDA 510(k) clearance for Maxxi Position Sensor by Neurovirtual USA, Inc.. It is a Class 2 Neurology device (product code GWQ) cleared through the Traditional 510(k) pathway after a 324-day FDA review.

K191492 · Neurovirtual USA, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2020
Decision
324d
Days
Class 2
Risk

K191492 is an FDA 510(k) clearance for the Maxxi Position Sensor. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Neurovirtual USA, Inc. (Fort Lauderdale, US). The FDA issued a Cleared decision on April 24, 2020 after a review of 324 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Neurovirtual USA, Inc. devices

Submission Details

510(k) Number K191492 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 05, 2019
Decision Date April 24, 2020
Days to Decision 324 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
176d slower than avg
Panel avg: 148d · This submission: 324d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 87
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K191492.
NeuroAmp II, NeuroAmp II.5s
K193159 · Corscience GmbH & Co. KG · Dec 2020
Neuronaute
K202334 · Bioserenity Sas · Dec 2020
Cadwell Apollo System
K201819 · Cadwell Industries, Inc. · Sep 2020
iCEWav Neuromonitoring Platform
K191868 · Ice Neurosystems, Inc. · Mar 2020
NeuralScan System
K192753 · Medeia, Inc. · Mar 2020
Cadwell Zenith System
K181466 · Cadwell Industries, Inc. · Sep 2018